NEWS

Remus Pharmaceuticals Limited IPO : Company Highlights

Remus Pharmaceuticals Limited IPO is set to launch on 17 May, 2023. The company initiated its business operations in the year 2005. Its business as the name suggests is related to the pharmaceutical sector. It is involved in distributing and marketing finished formulations for pharma drugs. It has 2 product categories namely APIs and Finished formulations of pharmaceuticals. The product portfolio includes more than 425 products. It has 295 products registered in 13 countries and 134 products registered in 16 countries. It has a network of 59 domestic and 139 international distributors.

Remus Pharmaceuticals Limited IPO DETAILS

Remus Pharmaceuticals Limited IPO is set to launch on 17 May., 2023. The subscription timeline extends till 19 May, 2023. The size for the IPO is 47.69 Crore Rs. Shares issued through fresh issue mode are worth 47.69 Crore Rs. No Shares are issued through offer for sale mode. The lot size is 100 shares and the price is 1150 to 1229 Rs per share. The company is going to get listed at NSE SME. The face value per share is Rs.10 and this is a Book Built issue. The registrar for the company is Link Intime India Private Limited.

Tabular Description of Remus Pharmaceuticals Limited IPO

IPO OPENING DATE	17 May., 2023
CLOSING DATE FOR IPO	19 May, 2023
ISSUE TYPE	Book Built Issue
Face Value per share	10 Rs. per share
IPO price band	1150 to 1229 Rs per share
LOT SIZE	100 shares
MINIMUM ORDER QUANTITY	100 shares
ISSUE SIZE	47.69 Crore Rs.
OFFER FOR SALE	No shares are issued through offer for sale mode.
FRESH ISSUE	47.69 Crore Rs.
LISTING AT	NSE SME
LISTING DATE	29 May, 2023

Remus Pharmaceuticals Limited IPO : IMPORTANT DATES

IPO OPENING DATE	17 May., 2023
CLOSING DATE FOR IPO	19 May., 2023
IPO ALLOTMENT DATE	24 May., 2023
REFUNDS	25 May., 2023
DEMAT A/C CREDITED ON	26 May., 2023
IPO LISTING DATE	29 May., 2023

Remus Pharmaceuticals Limited IPO begins for subscription from 17 May., 2023. The IPO subscription would continue till 19 May., 2023. The allotment status for the shareholders who applied would come on 24 May., 2023. The refunds for the ones who did not get allotment would be initiated on 25 May., 2023. The DEMAT accounts of shareholders would be credited on 26 May., 2023. The listing of the company would be accompanied on 29 May., 2023.

Remus Pharmaceuticals Limited IPO : Lead Managers

The lead managers are :

Beeline Capital Advisors Private Limited

The minimum lot size for the company is decided at 100 shares. This holding accounts to 122900 Rs.. The maximum lot size is decided at 200 shares (HNI). This amounts to 245800 Rs.. Hence the company’s final holdings would be set as :

	Shares	Amount
Minimum	100 shares	122900 Rs.
Maximum	200 shares	245800 Rs.

OBJECTIVES FOR THE IPO

IPO proceeds would be used for general corporate purposes.
The Issue proceeds will be utilised for fulfilling the working capital requirements.

COMPANY FINANCIALS

Particularly (in Lakh Rs.)	2019-20	2020-21	2021-22
ASSETS	530	1104	1590
Revenue	1276	1922	2543
PAT	81	102	338

Remus Pharmaceuticals Limited had an asset base of more than 530 Lklah Rs in 2020. This increased to 1105 Lakh Rs in 2021. This means the assets of the company doubled within a year. Also in 2022 the assets increased to a total of 1590 Lakh Rs. The revenue of the firm has been 1276 Lakh Rs in 2020. This went on to 1922 Lkah Rs in 2021 and 2543 Lakh Rs in 2022. Thus in 2 years the revenue of the firm also doubled. The company has been profitable in the last 3 years as well. The profit of the firm was 81 Lakh Rs in 2020. This went on to 102 Lkah Rs in 2021 and 338 Lakh Rs in 2022.

PROS

It has 2 product categories namely APIs and Finished formulations of pharmaceuticals.
The product portfolio includes more than 425 products.
It has 295 products registered in 13 countries and 134 products registered in 16 countries.
The company has a network of 59 domestic and 139 international distributors.